All In MedTech

Indication · GI, Urology & Nephrology

Liver disease and liver cancer

Devices FDA has cleared or approved since 2000 for liver disease and liver cancer, found through the 38 FDA device types (product codes) used for it, plus device trials and research. Also searched as: liver cirrhosis, hepatocellular carcinoma, liver cancer, NASH, portal hypertension.

Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov

Breakthrough-designated devices

3 more devices with a free account

Devices

168 devices via 510(k). PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.

AllPMADe Novo510(k)
  • LIAISON Anti-HAV

    DiaSorin, Inc. · 510(k) · Hepatitis A Test (Antibody And Igm Antibody) · newest 2022 · 4 decisions

59 more devices with a free account

Showing the first 60. Narrow by pathway, or open a device type below.

Device trials

Device studies on ClinicalTrials.gov for this condition, any status, newest update first.

Open in Trial Radar

692 more trials with a free account

Device types

FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.

Research

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.